Validation of a Circulating Tumor DNA ‐Based Next‐Generation Sequencing Assay in a Cohort of Patients with Solid tumors: A Proposed Solution for Decentralized Plasma Testing
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Validation of a Circulating Tumor
DNA
‐Based
Next‐Generation
Sequencing Assay in a Cohort of Patients with Solid tumors: A Proposed Solution for Decentralized Plasma Testing
Authors
Keywords
-
Journal
ONCOLOGIST
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2021-07-19
DOI
10.1002/onco.13905
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The potential of combined mutation sequencing of plasma circulating cell‐free DNA and matched white blood cells for treatment response prediction
- (2020) Paul Leest et al. Molecular Oncology
- The predictive and prognostic significance of cell‐free DNA concentration in melanoma
- (2020) R. Váraljai et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Fusions involving BCOR and CREBBP are rare events in infiltrating glioma
- (2020) David J. Pisapia et al. Acta Neuropathologica Communications
- Next generation sequencing of tissue and circulating tumor DNA: The UC San Diego Moores Center for Personalized Cancer Therapy experience with breast malignancies
- (2019) Rebecca Shatsky et al. MOLECULAR CANCER THERAPEUTICS
- Recent advances in circulating nucleic acids in oncology
- (2019) A Otandault et al. ANNALS OF ONCOLOGY
- Total circulating cell-free DNA as a prognostic biomarker in metastatic colorectal cancer before first-line oxaliplatin-based chemotherapy
- (2019) J Hamfjord et al. ANNALS OF ONCOLOGY
- Liquid biopsy in the era of immuno-oncology: is it ready for prime-time use for cancer patients?
- (2019) P Hofman et al. ANNALS OF ONCOLOGY
- Noninvasive Detection of Microsatellite Instability and High Tumor Mutation Burden in Cancer Patients Treated with PD-1 Blockade
- (2019) Andrew Georgiadis et al. CLINICAL CANCER RESEARCH
- Assessing the Concordance of Genomic Alterations between Circulating-Free DNA and Tumour Tissue in Cancer Patients
- (2019) Leila Jahangiri et al. Cancers
- RAS mutation analysis in circulating tumor DNA from patients with metastatic colorectal cancer: the AGEO RASANC prospective multicenter study
- (2018) J B Bachet et al. ANNALS OF ONCOLOGY
- Comparison of plasma ctDNA and tissue/cytology-based techniques for the detection of EGFR mutation status in advanced NSCLC: Spanish data subset from ASSESS
- (2018) E. Arriola et al. Clinical & Translational Oncology
- Utility of Liquid Biopsy by Improved PNA-LNA PCR Clamp Method for Detecting EGFR Mutation at Initial Diagnosis of Non–Small-Cell Lung Cancer: Observational Study of 190 Consecutive Cases in Clinical Practice
- (2018) Kentaro Ito et al. Clinical Lung Cancer
- Analytical Validation of a Hybrid Capture–Based Next-Generation Sequencing Clinical Assay for Genomic Profiling of Cell-Free Circulating Tumor DNA
- (2018) Travis A. Clark et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Cell-Free DNA in Oncology: Gearing up for Clinic
- (2018) Bryan C. Ulrich et al. Annals of Laboratory Medicine
- A machine learning approach for somatic mutation discovery
- (2018) Derrick E. Wood et al. Science Translational Medicine
- Measuring KRAS Mutations in Circulating Tumor DNA by Droplet Digital PCR and Next-Generation Sequencing
- (2018) Christina Demuth et al. Translational Oncology
- Clinical utility of plasma-based digital next-generation sequencing in patients with advance-stage lung adenocarcinomas with insufficient tumor samples for tissue genotyping
- (2018) J Zugazagoitia et al. ANNALS OF ONCOLOGY
- Guidelines for Validation of Next-Generation Sequencing–Based Oncology Panels
- (2017) Lawrence J. Jennings et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Direct detection of early-stage cancers using circulating tumor DNA
- (2017) Jillian Phallen et al. Science Translational Medicine
- Circulating Cell-Free Tumor DNA Analysis of 50 Genes by Next-Generation Sequencing in the Prospective MOSCATO Trial
- (2016) C. Jovelet et al. CLINICAL CANCER RESEARCH
- Evaluation and comparison of two commercially available targeted next-generation sequencing platforms to assist oncology decision making
- (2015) Glen Weiss et al. OncoTargets and Therapy
- The oestrogen receptor alpha-regulated lncRNA NEAT1 is a critical modulator of prostate cancer
- (2014) Dimple Chakravarty et al. Nature Communications
- MSIsensor: microsatellite instability detection using paired tumor-normal sequence data
- (2013) Beifang Niu et al. BIOINFORMATICS
- Prognostic and predictive roles for circulating biomarkers in gastrointestinal cancer
- (2011) Leticia De Mattos-Arruda et al. Future Oncology
- Development of Personalized Tumor Biomarkers Using Massively Parallel Sequencing
- (2010) R. J. Leary et al. Science Translational Medicine
- Fast and accurate short read alignment with Burrows-Wheeler transform
- (2009) H. Li et al. BIOINFORMATICS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now